Monteplase

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by AnomieBOT (talk | contribs) at 16:48, 11 October 2018 (Substing templates: {{Incomplete}}. See User:AnomieBOT/docs/TemplateSubster for info.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Monteplase is an antithrombic proposed for use in acute myocardial infarction.[1][2]

References

  1. ^ Inoue T, Nishiki R, Kageyama M, Node K (2005). "Therapeutic potential of monteplase in acute myocardial infarction". Am J Cardiovasc Drugs. 5 (4): 225–31. doi:10.2165/00129784-200505040-00002. PMID 15984905.
  2. ^ Inoue T; Nishiki R; Kageyama M; et al. (February 2005). "Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction". Am. J. Cardiol. 95 (4): 506–8. doi:10.1016/j.amjcard.2004.09.061. PMID 15695140. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)


Stub icon

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Monteplase&oldid=863572139"